Pieris Pharmaceuticals Inc (PIRS)
10.90
-0.48
(-4.18%)
USD |
NASDAQ |
May 03, 13:43
Pieris Pharmaceuticals 1 Year Total Returns (Daily): -81.61% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -81.61% |
May 01, 2024 | -80.38% |
April 30, 2024 | -80.63% |
April 29, 2024 | -80.63% |
April 26, 2024 | -81.10% |
April 25, 2024 | -81.93% |
April 24, 2024 | -82.86% |
April 23, 2024 | -81.25% |
April 22, 2024 | -81.74% |
April 19, 2024 | -82.53% |
April 18, 2024 | -81.07% |
April 17, 2024 | -80.96% |
April 16, 2024 | -77.16% |
April 15, 2024 | -76.33% |
April 12, 2024 | -77.12% |
April 11, 2024 | -76.80% |
April 10, 2024 | -77.45% |
April 09, 2024 | -76.69% |
April 08, 2024 | -77.81% |
April 05, 2024 | -80.48% |
April 04, 2024 | -81.15% |
April 03, 2024 | -82.23% |
April 02, 2024 | -81.76% |
April 01, 2024 | -80.84% |
March 28, 2024 | -87.62% |
Date | Value |
---|---|
March 27, 2024 | -85.16% |
March 26, 2024 | -85.08% |
March 25, 2024 | -85.58% |
March 22, 2024 | -83.61% |
March 21, 2024 | -84.62% |
March 20, 2024 | -82.64% |
March 19, 2024 | -82.19% |
March 18, 2024 | -82.64% |
March 15, 2024 | -88.42% |
March 14, 2024 | -87.87% |
March 13, 2024 | -87.55% |
March 12, 2024 | -86.85% |
March 11, 2024 | -86.92% |
March 08, 2024 | -88.00% |
March 07, 2024 | -87.73% |
March 06, 2024 | -88.26% |
March 05, 2024 | -88.22% |
March 04, 2024 | -88.36% |
March 01, 2024 | -88.39% |
February 29, 2024 | -88.99% |
February 28, 2024 | -88.66% |
February 27, 2024 | -89.29% |
February 26, 2024 | -88.06% |
February 23, 2024 | -89.09% |
February 22, 2024 | -89.03% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.85%
Minimum
Jul 07 2023
194.4%
Maximum
Sep 27 2021
-26.44%
Average
-30.20%
Median
Jun 10 2019
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -91.96% |
Palatin Technologies Inc | -6.82% |
iBio Inc | -90.77% |
Theriva Biologics Inc | -37.61% |
Oragenics Inc | -62.50% |